These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2303284)

  • 1. Hemodynamic changes by recombinant erythropoietin therapy in hemodialyzed patients.
    Satoh K; Masuda T; Ikeda Y; Kurokawa S; Kamata K; Kikawada R; Takamoto T; Marumo F
    Hypertension; 1990 Mar; 15(3):262-6. PubMed ID: 2303284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
    Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
    Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
    Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis.
    Martinez-Vea A; Bardají A; García C; Ridao C; Richart C; Oliver JA
    Am J Kidney Dis; 1992 Apr; 19(4):353-7. PubMed ID: 1532883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Fernández A; Vega N; Jiménez F; Macía M; Laraudiogoitía E; Hortal L; Perdomo M; Plaza C; Rodríguez JC; Palop L
    Am J Nephrol; 1992; 12(4):207-11. PubMed ID: 1481867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin.
    Goldberg N; Lundin AP; Delano B; Friedman EA; Stein RA
    Am Heart J; 1992 Aug; 124(2):424-7. PubMed ID: 1386184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renormalization of high cardiac output and of left ventricular size following long-term recombinant human erythropoietin treatment of anemic dialyzed uremic patients.
    Cannella G; La Canna G; Sandrini M; Gaggiotti M; Nordio G; Movilli E; Maiorca R
    Clin Nephrol; 1990 Dec; 34(6):272-8. PubMed ID: 2073771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could CAPD modulate the hemodynamic changes induced by rHuEPO treatment?
    Fernández A; Vega N; Hortal L; Jimenez F; Laraudogoitía E; Macía M; Plaza C; Perdomo M; Palop L
    Adv Perit Dial; 1992; 8():435-9. PubMed ID: 1361842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
    Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
    Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
    Schwartz AB; Prior JE; Mintz GS; Kim KE; Kahn SB
    Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.
    Löw I; Grützmacher P; Bergmann M; Schoeppe W
    Clin Nephrol; 1989 Jan; 31(1):26-30. PubMed ID: 2521587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic changes in hemodialyzed patients during treatment with recombinant human erythropoietin.
    Teruel JL; Pascual J; Jiménez M; Liaño F; Rivera M; Martínez J; Moya JL; Ortuño J
    Nephron; 1991; 58(2):135-7. PubMed ID: 1865967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the 6-month anemia therapy with erythropoietin on renal function and some hemodynamic parameters in predialysis patients.
    Tomczak-Watras W; Strózecki P; Zuchora Z; Szefer J; Manitius J
    Pol Arch Med Wewn; 2009; 119(1-2):45-51. PubMed ID: 19341178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant human erythropoietin (r-HuEPO) on left ventricular mass and left ventricular hemodynamics in hemodialysis patients.
    Minagawa T; Hirano T; Takada N; Ishiguro M; Ohtsuka H
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):934-41. PubMed ID: 7933670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin.
    Abdulhadi MH; Fouad-Tarazi FM; Thomas T; Bravo EL; Paganini EP
    Nephrol Dial Transplant; 1990; 5 Suppl 1():102-8. PubMed ID: 2129437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin.
    London GM; Zins B; Pannier B; Naret C; Berthelot JM; Jacquot C; Safar M; Drueke TB
    Kidney Int; 1989 Nov; 36(5):878-82. PubMed ID: 2615194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy].
    Dzgoeva FU; Gatagonova TM; Kadzaeva ZK; Khamitsaeva OV; Kochisova ZKh; Dzueva AT; Bazaeva BG; Bestaeva TL
    Ter Arkh; 2013; 85(6):44-50. PubMed ID: 23866598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term echocardiographic examinations in chronic hemodialysis patients substituted with recombinant human erythropoietin.
    Löw-Friedrich I; Grützmacher P; März W; Bergmann M; Schoeppe W
    Blood Purif; 1990; 8(5):272-8. PubMed ID: 2151114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.